Skip to main content

Table 1 Literature for patients treated with chemotherapy against skin metastasis arising from squamous cervical carcinoma without other metastasis

From: Successful management of cutaneous lymphangitis carcinomatosa arising from cervical cancer with paclitaxel-cisplatin and bevacizumab combination therapy: a case report and review of the literature

Author/Year

Stage/Histology/Grade

Site of skin metastasis

Chemotherapy regime

Cycles

Best response

This report/2019

IB1/SCC/Differentiated

Thigh and vulva

PTX-CDDP-BV

6

CR

Özcan et al. [19]/2017

IB2/SCC/N/A

Vulva

1st line; PTX-CBDCA

2

PD

2nd line; GEM-BV

N/A

PD

IB1/SCC/N/A

Umbilicus (incisional scar), abdominal wall

1st line; PTX-CBDCA

1

N/A

2nd line; GEM-BV + RT

1

N/A

Benoulaid et al. [20]/2016

IIIB/SCC/Moderately differentiated

Abdominal wall

CBDCA

4

PD

Basu and Mukherjee [21]/2013

IIA/SCC/Moderately differentiated

Thigh, inguinal region

CDDP-PTX + palliative RT

6

PR

Behtash et al. [16]/2008

IIB/SCC/N/A

Umbilicus

PTX-CBDCA

6

PR

Behtash et al. [22]/2002

IIA/SCC/N/A

Abdominal wall (drain site)

Cisplatin-5FU + palliative RT

6

PR

Palaia et al. [23]/2002

IIB/SCC/Poorly differentiated

Abdominal wall

Palliative chemotherapy (PTX)

10

CR

Kagen et al. [24]/2001

IB/SCC/Poorly differentiated

Thigh

Ifosfamide

N/A

PD

Freeman et al. [25]/1982

IVB/SCC/N/A

Abdominal wall

RT + Bleomycin-MTX -cyclophosphamide

N/A

CR

  1. 5FU 5 fluorouracil, BV bevacizumab, CBDCA carboplatin, CDDP cisplatin, CR complete response, GEM gemcitabine, MTX methotrexate, N/A not assessed, PD progressive disease, PR partial response, PTX paclitaxel, RT radiotherapy, SCC squamous cell carcinoma